Accelerating your Discovery and development process
Multidimensional data approach designed to enhance efficiency and streamline immuno-oncology development
Designing treatments that work is a trial-and-error process. Javelin Oncology optimizes this process by integrating public and proprietary multidimensional data that encompasses target, therapy, and patient selection. Such analysis can reduce development costs by up to 90%. Our clinical trial services employ this approach to help you significantly reduce your discovery and development time and costs.
OUR SERVICES INCLUDE:
- Assess and prioritize target selection
- Apply patient stratification, targeting, and identification
- Vastly reduce population and time for clinical trials
- Assess the probability of success of discovery targets and clinical trials
We begin with an initial assessment, where we provide recommendations on the probability of success and areas of likely failure for a particular therapeutic or development program. We can also suggest ways to enhance discovery and development productivity.
Then we move to the deployment phase, where we assess specificity, activation, safety, patient stratification, and clinical trial design. We can also work with partners to identify and enroll patients for trials.
For those seeking further assistance, we can provide discovery tools, CARs, activation, and safety capabilities for their therapies.
Learn more about how Javelin Oncology can help you accelerate your immuno-oncology therapy development pipeline
Javelin assesses the level of saving and improvements that can be delivered